Safety Alerts
4 articles on Safety Alerts, researched and written by the Shotlee Editorial Team from primary sources.
RFK Jr. and the Perils of Unapproved Peptides
The mantra 'once an accident, twice a coincidence, three times a trend' fuels bad journalism—and worse, risky medicine. A New Yorker investigation exposes clinics pushing unproven peptides for healing and longevity, backed by RFK Jr. While semaglutide proves the exception, most lack evidence and pose real harms.
5 min read
Taiwan FDA Warns: GLP-1 Weight Loss Drugs Like Ozempic Linked to 21 Adverse R...
Taiwan's Food and Drug Administration (FDA) has reported 21 cases of suspected adverse reactions to GLP-1 receptor agonists like Ozempic used for weight loss. Symptoms include gastrointestinal disorders, hypoglycemia, nausea, and more. Amid global concerns from US lawsuits and UK pancreatitis warnings, the FDA urges doctor-prescribed use only.
5 min read
GLP-1 News 2025: Safety Alerts, Fakes & Breakthroughs
GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound now make up over 7% of U.S. prescriptions, fueling weight loss trends but raising safety concerns. From FDA warnings on sharing pens to charges over fake drugs, here's what patients need to know. Discover emerging research and tools to manage your therapy safely.
4 min read
Australia Issues Mental Health Alert for Weight-Loss Medications Like Ozempic
The Therapeutic Goods Administration (TGA) has issued new safety alerts concerning weight loss and diabetes medications. These warnings address potential mental health risks and reduced effectiveness of oral contraceptives when using drugs like Mounjaro.
2 min read